KG Jebsen B-cell malignancies

A review of the new European myeloma guidelines. bpno.no/medtalks/eha-e…

Suksess med ny behandling for myelomatose. vg.no/forbruker/hels…

Can we hope that CAR-T will be approved for Norwegian patients in 2021? healthtalk.no/alle-artikler/…

Two of our KG Jebsen PIs (Munthe and Tjønnfjord) were part of the team who discovered the mechanisms behind the very rare but life-threatening condition after ChAdOx1 nCoV-19 Vaccination | NEJM nejm.org/doi/full/10.10… @stiftkgj

tekniskmuseum.no/program/13-feb… Come to Teknisk museum on thursday to visit our Cellfie-stand! Fun for the whole family and free of charge 18-20 @LabMyklebust @kg_cell

Outstanding talk by our former PhD student Chloe Steen at ASH today!! She is now successful postdoc in the Alizadeh lab at Stanford!@UniOslo_MED @kg_cell

Great interest for the results from the clinical phase III study, testing efficacy of anti-CD38 antibody Isatuximab with Pomalidomide and Dexamethasone in Multiple Myeloma, presented by Fredrik Schjesvold (our KG Jebsen centre/Oslo Myeloma centre) @MyelomaOslo @UniOslo_MED

Amazing talk by Baoyan Bay at ASH today, presenting our data on tumor genome evolution in follicular lymphoma

Kathrine is doing a great job, presenting the DLBCL90 Gene expresssion assay for predicting double hit lymphoma at ASH

Great interest for Jillians work, focused on immune escape and mutational dynamics in Diffuse large B cell lymphoma

Ph.D. student Johanne Vestbøstad from our Jebsen center was awarded "Best Poster Presentation" at the Norwegian Society of Immunology Annual meeting. Congratulations!! @OusResearch @stiftkgj

Cake celebration as Peter Huszthy and Ramakrishna Gopalakrishnan et al receive news that their paper has been accepted in PNAS (B cell receptor ligation induces display of V-region peptides on MHC class II molecules to T cells). Congratulations!

Excited for Jillian’s @jillianmcwise Nature News @NatureNV on 2,520 WGS metastatic cancer sites, a great effort by @ecuppen and collegues. nature.com/articles/d4158…

Big congratulations to Fredrik Schjesvold who received funding from the Norwegian Cancer Society today! The clinical study, called REMNANT, is designed to determine if early detection and treatment of relapse will improve the prognosis for multiple myeloma patients. @stiftkgj

The Jebsen foundation treated participants at the Annual meting to music from Ole Bull and Edvard Grieg at Ole Bulls Home from 1860 at Lysøen outside Bergen. Fantastic music and architecture.

June, Fredrik and Ludvig are at the KG Jebsen stiftelsen Annual Retreat in the beautiful Solstrand Hotel. This is also the 10 year anniversary of the foundation. Topics: Patient and public involvement, GDPR, clinical trials, personalized medicine.

Great science and great fun at the KG Jebsen Center for B-cell malignancies Annual Retreat

Great talks and great fun at KG Jebsen Ctr for B cell malignancies, @kg_cell, retreat and SAB visit. @Oslounivsykehus @MyelomaOslo @UniOslo_MED @TaskenLab @LabMyklebust #PrecisionMedicine @Blodkreft_Nor @Lymfekrforening @stiftkgj

Collecting beautiful Hyperion images